The latest research from the American Institute for Cancer Research and the World Cancer Research Fund highlights several factors that increase the risk of stomach cancer.
Researchers have pinpointed various drugs typically used to treat diseases such as heart failure and infections that could also be beneficial in treating cancers.
The FDA has approved new options for the treatment of melanoma lesions, soft tissue sarcomas, and the rare metabolic disease, hypophosphatasia, that clinicians should be aware of.